Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Lotus Eye Hospital and Institute Yönetim
Yönetim kriter kontrolleri 4/4
Lotus Eye Hospital and Institute's CEO is Kuttapalayam Ramalingam, appointed in Aug 2020, has a tenure of 4.17 years. directly owns 1.43% of the company’s shares, worth ₹24.58M. The average tenure of the management team and the board of directors is 4.1 years and 4.8 years respectively.
Anahtar bilgiler
Kuttapalayam Ramalingam
İcra Kurulu Başkanı
₹1.2m
Toplam tazminat
| CEO maaş yüzdesi | n/a |
| CEO görev süresi | 4.2yrs |
| CEO sahipliği | 1.4% |
| Yönetim ortalama görev süresi | 4.1yrs |
| Yönetim Kurulu ortalama görev süresi | 4.8yrs |
Son yönetim güncellemeleri
Recent updates
Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking
Aug 21
Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings
Jan 24Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 08We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Jul 15Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors
Apr 07We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Oct 08Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 02If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity
Jun 17MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Mar 11Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Dec 30Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares
Nov 20The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares
Sep 21Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E
Aug 27
Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?
Aug 03Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises
Jul 06CEO
Kuttapalayam Ramalingam (74 yo)
4.2yrs
Görev süresi
₹1,200,000
Tazminat
Dr. Kuttapalayam Songappan Ramalingam, M.D., serves as an Executive Director at Lotus Eye Hospital and Institute Limited since February 10, 2021. Dr. Ramalingam serves as Chief Executive Officer at Lotus E...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO & Executive Director | 4.2yrs | ₹1.20m | 1.43% ₹ 24.6m | |
| Chief Financial Officer | 2.4yrs | ₹1.70m | Veri yok | |
| Company Secretary & Compliance Officer | 2.7yrs | ₹1.08m | Veri yok | |
| MD & Director | 4.1yrs | ₹3.09m | 18.84% ₹ 322.8m | |
| Vice President of Administration | 6.4yrs | Veri yok | 0.21% ₹ 3.5m |
4.1yrs
Ortalama Görev Süresi
67yo
Ortalama Yaş
Deneyimli Yönetim: LOTUSEYE's management team is considered experienced (4.1 years average tenure).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO & Executive Director | 3.7yrs | ₹1.20m | 1.43% ₹ 24.6m | |
| MD & Director | 4.9yrs | ₹3.09m | 18.84% ₹ 322.8m | |
| Vice President of Administration | 4.8yrs | Veri yok | 0.21% ₹ 3.5m | |
| Non-Executive Independent Director | 17yrs | ₹200.00k | Veri yok | |
| Chairman of the Board | 8.4yrs | ₹150.00k | 18.78% ₹ 321.8m | |
| Non-Executive Independent Director | 17yrs | ₹200.00k | Veri yok | |
| Non-Executive Independent Director | 12.4yrs | ₹200.00k | Veri yok | |
| Independent Director | 3.8yrs | ₹200.00k | Veri yok | |
| Independent Non-Executive Director | 1.8yrs | ₹200.00k | Veri yok | |
| Independent Non-Executive Director | 1.7yrs | ₹175.00k | Veri yok |
4.8yrs
Ortalama Görev Süresi
75yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: LOTUSEYE's board of directors are considered experienced (4.8 years average tenure).